Chih-Wei Lin

1.1k total citations
11 papers, 400 citations indexed

About

Chih-Wei Lin is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Chih-Wei Lin has authored 11 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hepatology and 3 papers in Molecular Biology. Recurrent topics in Chih-Wei Lin's work include Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver Disease and Transplantation (2 papers). Chih-Wei Lin is often cited by papers focused on Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver Disease and Transplantation (2 papers). Chih-Wei Lin collaborates with scholars based in United States, France and New Zealand. Chih-Wei Lin's co-authors include Jens Kort, Federico Mensa, Richard A. Lerner, Fred Poordad, Tarek Hassanein, Stanley Wang, Nicholas C. Wu, Paul Y. Kwo, Sandra Lovell and David Wyles and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Gastroenterology.

In The Last Decade

Chih-Wei Lin

11 papers receiving 392 citations

Peers

Countries citing papers authored by Chih-Wei Lin

Since Specialization

Citations

This map shows the geographic impact of Chih-Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih-Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih-Wei Lin more than expected).

Fields of papers citing papers by Chih-Wei Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih-Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih-Wei Lin. The network helps show where Chih-Wei Lin may publish in the future.

Co-authorship network of co-authors of Chih-Wei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chih-Wei Lin. A scholar is included among the top collaborators of Chih-Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih-Wei Lin. Chih-Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	A cell–cell interaction format for selection of high-affinity antibodies to membrane proteins 2019 ·Proceedings of the National Academy of Sciences ·(unknown), Yue Wan, (unknown), Min Qiang, Xue Dong, Chih-Wei Lin, Guang Yang, Tianqing Zheng, Richard A. Lerner	32
2	Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1–6 Hepatitis C Virus Infections and Compensated Liver Disease 2019 ·Clinical Infectious Diseases ·Edward Gane, Fred Poordad, Neddie Zadeikis, Joaquin Valdes, Chih-Wei Lin, Wei Liu, Armen Asatryan, Stanley Wang, Catherine Stedman, Susan Greenbloom, Tuan Nguyen, Magdy Elkhashab, Marcus‐Alexander Wörns, Albert Tran, (unknown), Carolyn M. Setze, Yao Yu, Edward Tam, Ariel Porcalla, Federico Mensa	23
3	Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility 2019 ·Cell Host & Microbe ·Nicholas C. Wu, Huibin Lv, Andrew J. Thompson, Douglas C. Wu, Wilson W. Ng, Rameshwar U. Kadam, Chih-Wei Lin, Corwin M. Nycholat, Ryan McBride, Weiwen Liang, James C. Paulson, Chris Ka Pun Mok, Ian A. Wilson	42
4	Immunity against cancer cells may promote their proliferation and metastasis 2019 ·Proceedings of the National Academy of Sciences ·Chih-Wei Lin, Jia Xie, Ding Zhang, Kyung Ho Han, (unknown), Nicholas C. Wu, (unknown), Kyungmoo Yea, Richard A. Lerner	14
5	Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection 2018 ·Clinical Gastroenterology and Hepatology ·Steven L. Flamm, K. Rajender Reddy, Neddie Zadeikis, Tarek Hassanein, Bruce R. Bacon, A Maieron, Stefan Zeuzem, Marc Bourlière, José Luís Calleja, Matthew P. Kosloski, Rajneet K. Oberoi, Chih-Wei Lin, Yao Yu, Sandra Lovell, Dimitri Semizarov, Federico Mensa	17
6	A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site 2018 ·Nature Communications ·Nicholas C. Wu, Andrew J. Thompson, Jia Xie, Chih-Wei Lin, Corwin M. Nycholat, Xueyong Zhu, Richard A. Lerner, James C. Paulson, Ian A. Wilson	54
7	A new method for detection of single nucleotide polymorphism in a female reproduction-associated gene, tmigd1, of Anas platyrhynchos using a strip biosensor with gold nanoparticles 2018 ·Poultry Science ·Chih-Wei Lin, Jui‐Chao Kuo, (unknown), (unknown), (unknown)	4
8	Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial 2017 ·Hepatology ·David Wyles, Fred Poordad, Stanley Wang, Laurent Alric, Franco Felizarta, Paul Y. Kwo, Benedict Maliakkal, Kosh Agarwal, Tarek Hassanein, Frank Weilert, (unknown), Jens Kort, Sandra Lovell, Ran Liu, Chih-Wei Lin, Edward Tam, Preethi Krishnan, Federico Mensa	99
9	High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis 2016 ·Gastroenterology ·Edward Gane, Fred Poordad, Stanley Wang, Armen Asatryan, Paul Y. Kwo, Jacob Lalezari, David Wyles, Tarek Hassanein, Humberto Aguilar, Benedict Maliakkal, Ran Liu, Chih-Wei Lin, Teresa I. Ng, Jens Kort, Federico Mensa	72
10	Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection 2015 ·Antimicrobial Agents and Chemotherapy ·Eric Lawitz, William O’Riordan, Armen Asatryan, B. Freilich, Terry Box, J. Scott Overcash, Sandra Lovell, Teresa I. Ng, Wei Liu, Andrew Campbell, Chih-Wei Lin, Betty Yao, Jens Kort	40
11	P0715 : Steady-state pharmacokinetics and safety of coadministration of pan-genotypic, direct acting protease inhibitor, ABT-493 with pan-genotypic NS5A inhibitor, ABT-530, in healthy adult subjects 2015 ·Journal of Hepatology ·Chih-Wei Lin, (unknown), Armen Asatryan, Andrew Campbell, (unknown), (unknown), (unknown), (unknown), Jens Kort, Sheetij Dutta	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact